78 related articles for article (PubMed ID: 15796899)
1. In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker.
Sonta T; Inoguchi T; Matsumoto S; Yasukawa K; Inuo M; Tsubouchi H; Sonoda N; Kobayashi K; Utsumi H; Nawata H
Biochem Biophys Res Commun; 2005 May; 330(2):415-22. PubMed ID: 15796899
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes.
Sano T; Umeda F; Hashimoto T; Nawata H; Utsumi H
Diabetologia; 1998 Nov; 41(11):1355-60. PubMed ID: 9833944
[TBL] [Abstract][Full Text] [Related]
3. Evalution of oxidative stress in diabetic animals by in vivo electron spin resonance measurement--role of protein kinase C.
Sonta T; Inoguchi T; Tsubouchi H; Sekiguchi N; Kobayashi K; Matsumoto S; Utsumi H; Nawata H
Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S109-13. PubMed ID: 15563958
[TBL] [Abstract][Full Text] [Related]
4. In vivo imaging of oxidative stress in ischemia-reperfusion renal injury using electron paramagnetic resonance.
Hirayama A; Nagase S; Ueda A; Oteki T; Takada K; Obara M; Inoue M; Yoh K; Hirayama K; Koyama A
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F597-603. PubMed ID: 15536173
[TBL] [Abstract][Full Text] [Related]
5. Diltiazem attenuates oxidative stress in diabetic rats.
Anjaneyulu M; Chopra K
Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M
J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
[TBL] [Abstract][Full Text] [Related]
7. In vivo imaging of renal redox status during azelnidipine treatment.
Hirayama A; Ueda A; Oteki T; Nagase S; Aoyagi K; Koyama A
Hypertens Res; 2008 Aug; 31(8):1643-50. PubMed ID: 18971540
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
[TBL] [Abstract][Full Text] [Related]
9. Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress.
Hamada Y; Kitazawa S; Kitazawa R; Fujii H; Kasuga M; Fukagawa M
Bone; 2007 May; 40(5):1408-14. PubMed ID: 17251074
[TBL] [Abstract][Full Text] [Related]
10. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
Hamada Y; Fukagawa M
Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of thioredoxin1 in transgenic mice suppresses development of diabetic nephropathy.
Hamada Y; Miyata S; Nii-Kono T; Kitazawa R; Kitazawa S; Higo S; Fukunaga M; Ueyama S; Nakamura H; Yodoi J; Fukagawa M; Kasuga M
Nephrol Dial Transplant; 2007 Jun; 22(6):1547-57. PubMed ID: 17360766
[TBL] [Abstract][Full Text] [Related]
12. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
[TBL] [Abstract][Full Text] [Related]
13. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
14. Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats.
Awad AS; Webb RL; Carey RM; Siragy HM
Am J Hypertens; 2005 Apr; 18(4 Pt 1):544-8. PubMed ID: 15831366
[TBL] [Abstract][Full Text] [Related]
15. An angiotensin II receptor blocker increases sexual behavior in type 2 diabetic mice.
Nomura M; Nishii H; Ozaki Y; Fujimoto N; Matsumoto T
Physiol Behav; 2007 Jun; 91(2-3):223-8. PubMed ID: 17434545
[TBL] [Abstract][Full Text] [Related]
16. Activation of oxidative stress signaling that is implicated in apoptosis with a mouse model of diabetic embryopathy.
Yang P; Zhao Z; Reece EA
Am J Obstet Gynecol; 2008 Jan; 198(1):130.e1-7. PubMed ID: 18166327
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
Tamura J; Konno A; Hashimoto Y; Kon Y
Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
[TBL] [Abstract][Full Text] [Related]
18. The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice.
Xu S; Jiang B; Maitland KA; Bayat H; Gu J; Nadler JL; Corda S; Lavielle G; Verbeuren TJ; Zuccollo A; Cohen RA
Diabetes; 2006 Jan; 55(1):110-9. PubMed ID: 16380483
[TBL] [Abstract][Full Text] [Related]
19. Reduction of albuminuria by angiotensin receptor blocker beyond blood pressure lowering: evaluation in megsin/receptor for advanced glycation end products/inducible nitric oxide synthase triple transgenic diabetic nephropathy mouse model.
Ohtomo S; Ito M; Izuhara Y; Van Ypersele De Strihou C; Miyata T
Nephrology (Carlton); 2008 Dec; 13(6):517-21. PubMed ID: 18363646
[TBL] [Abstract][Full Text] [Related]
20. Are free radical reactions increased in the diabetic eye?
Yamato M; Matsumoto S; Ura K; Yamada K; Naganuma T; Inoguchi T; Watanabe T; Utsumi H
Antioxid Redox Signal; 2007 Mar; 9(3):367-73. PubMed ID: 17184178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
